Search - tctmd.com

Displaying 981 - 1000 of 2424

Sort: Relevancy | Date

Presentation TCT 2017

Case Presentation: A Patient With Multivessel Disease in STEMI

Presenter: Stefan K. James, Ran Kornowski, Marco V. Wainstein

October 31, 2017

Presentation TCT 2017

Multivessel PCI Debate: Based on What We Know Today - Culprit Lesion Only PCI With Watchful Waiting Is the Preferred Strategy!

Presenter: Stefan K. James, Ran Kornowski, Deepak L. Bhatt

October 31, 2017

Presentation TCT 2017

Multivessel PCI Debate: Based on What We Know Today - Culprit Lesion Only PCI With Staged Revascularization After Ischemia Testing Is the Preferred Strategy!

Presenter: Stefan K. James, Ran Kornowski, Thomas Engstroem

October 31, 2017

Presentation TCT 2017

Multivessel PCI Debate: Based on What We Know Today - Immediate Multivessel PCI Is the Preferred Strategy!

Presenter: Stefan K. James, Ran Kornowski, Anthony H. Gershlick

October 31, 2017

Presentation TCT 2017

When, If Ever, Should Stent Implantation Be Deferred in STEMI?

Presenter: Stefan K. James, Ran Kornowski, Jacob Lønborg, MD

October 31, 2017

Presentation TCT 2017

Case Presentation: No Reflow After Primary PCI

Presenter: David P. Faxon, Robert S. Schwartz, Mohamed Abdel-Wahab

October 31, 2017

Presentation TCT 2017

Manual Aspiration Thrombectomy in STEMI: Do Any Subgroups Benefit?

Presenter: David P. Faxon, Robert S. Schwartz, Stefan K. James

October 31, 2017

Presentation TCT 2017

Intracoronary Pharmacology: Approach to Thrombus and the Prevention and Treatment of No Reflow

Presenter: David P. Faxon, Robert S. Schwartz, Raffaele Piccolo

October 31, 2017

Presentation TCT 2017

Coronary Flow, Collateral Flow, and Fractional Flow Reserve in Culprit and Nonculprit Lesions in STEMI

Presenter: David P. Faxon, Robert S. Schwartz, Matthias Götberg

October 31, 2017

Presentation TCT 2017

Recognition, Diagnosis, and Management of Spontaneous Coronary Artery Dissection

Presenter: David P. Faxon, Robert S. Schwartz, Jacqueline Saw

October 31, 2017

Presentation TCT 2017

Trials With Cardiac Derived Cells: CAREMI and ALLSTAR

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz

October 31, 2017

Presentation TCT 2017

US Trial Background and Update: Preserve-AMI

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Jose M. de la Torre Hernandez

October 31, 2017

Presentation TCT 2017

VALIDATE-SWEDEHEART NSTEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With NSTEMI

Presenter: Thomas F. Luscher, David Erlinge

October 31, 2017

Presentation TCT 2017

TCT 5: Complete vs Culprit Only Lesion Intervention in ACS Patients With Multivessel Disease - Incidence and Outcomes From The London Heart Attack Group

Presenter: David A. Cox, Alice K. Jacobs, Krishnaraj Rathod, MD

October 31, 2017

Presentation TCT 2017

TCT 4: Prognostic Impact of Nonculprit Chronic Total Occlusions in Infarct-Related Cardiogenic Shock - Results of the Randomized IABP-SHOCK II Trial

Presenter: Rajesh M. Dave, A. Michael Lincoff, Mohammed Saad, MD

October 31, 2017

Presentation TCT 2017

VALIDATE-SWEDEHEART STEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With STEMI

Presenter: Y. S. Chandrashekhar, David J. Moliterno, Stefan K. James

October 31, 2017

Presentation TCT 2017

TCT 3: Outcomes of Left Main Revascularization in Patients With Acute Coronary Syndrome vs Stable Angina: Analysis From the EXCEL Trial

Presenter: Rajesh M. Dave, A. Michael Lincoff, Marc Etienne Jolicoeur

October 31, 2017

Presentation TCT 2017

TCT 2: Coronary Angiographic Findings and Outcomes in Patients With Sudden Cardiac Arrest Without ST-Elevation Myocardial Infarction - A SWEDEHEART Study

Presenter: Rajesh M. Dave, A. Michael Lincoff, Sasha Koul, MD

October 31, 2017

Presentation TCT 2017

TCT 1: Direct Stenting Strategy Is Associated With Improved Outcomes in Patients With Totally Occluded Culprit Arteries Undergoing Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction

Presenter: Rajesh M. Dave, A. Michael Lincoff, Ivan Bessonov, MD

October 31, 2017

Advertisement

Case Presentation: A Patient With Multivessel Disease in STEMI

Multivessel PCI Debate: Based on What We Know Today - Culprit Lesion Only PCI With Watchful Waiting Is the Preferred Strategy!

Multivessel PCI Debate: Based on What We Know Today - Culprit Lesion Only PCI With Staged Revascularization After Ischemia Testing Is the Preferred Strategy!

Multivessel PCI Debate: Based on What We Know Today - Immediate Multivessel PCI Is the Preferred Strategy!

When, If Ever, Should Stent Implantation Be Deferred in STEMI?

Case Presentation: No Reflow After Primary PCI

Manual Aspiration Thrombectomy in STEMI: Do Any Subgroups Benefit?

Intracoronary Pharmacology: Approach to Thrombus and the Prevention and Treatment of No Reflow

Coronary Flow, Collateral Flow, and Fractional Flow Reserve in Culprit and Nonculprit Lesions in STEMI

Recognition, Diagnosis, and Management of Spontaneous Coronary Artery Dissection

Trials With Cardiac Derived Cells: CAREMI and ALLSTAR

US Trial Background and Update: Preserve-AMI

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

VALIDATE-SWEDEHEART NSTEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With NSTEMI

TCT 5: Complete vs Culprit Only Lesion Intervention in ACS Patients With Multivessel Disease - Incidence and Outcomes From The London Heart Attack Group

TCT 4: Prognostic Impact of Nonculprit Chronic Total Occlusions in Infarct-Related Cardiogenic Shock - Results of the Randomized IABP-SHOCK II Trial

VALIDATE-SWEDEHEART STEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With STEMI

TCT 3: Outcomes of Left Main Revascularization in Patients With Acute Coronary Syndrome vs Stable Angina: Analysis From the EXCEL Trial

TCT 2: Coronary Angiographic Findings and Outcomes in Patients With Sudden Cardiac Arrest Without ST-Elevation Myocardial Infarction - A SWEDEHEART Study

TCT 1: Direct Stenting Strategy Is Associated With Improved Outcomes in Patients With Totally Occluded Culprit Arteries Undergoing Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content